|
|
||||||||
|
FIGURE 3. KaplanMeier survival curves of NSCLC patients with high tumor SUV (weight-corrected mean SUVT > 10) on 18F-FDG PET vs. patients with less active primary tumors. Median survival of patients with elevated SUVT was significantly shorter (227 vs. 874 d; P = 0.003, log-rank test). T = primary tumor.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |